Provider willingness to screen all sexually active adolescents for chlamydia.

PubWeight™: 0.91‹?›

🔗 View Article (PMC 1744552)

Published in Sex Transm Infect on October 01, 2002

Authors

B O Boekeloo1, M H Snyder, M Bobbin, G R Burstein, D Conley, T C Quinn, J M Zenilman

Author Affiliations

1: Department of Public and Community Health, College of Health and Human Performance, University of Maryland, College Park, MD 20742, USA. bb153@umail.umd.edu

Articles cited by this

Incident Chlamydia trachomatis infections among inner-city adolescent females. JAMA (1998) 4.12

Screening for Chlamydia trachomatis in asymptomatic women attending family planning clinics. A cost-effectiveness analysis of three strategies. Ann Intern Med (1998) 2.78

Performance and cost-effectiveness of selective screening criteria for Chlamydia trachomatis infection in women. Implications for a national Chlamydia control strategy. Sex Transm Dis (1997) 2.42

Determinants of persistent and recurrent Chlamydia trachomatis infection in young women: results of a multicenter cohort study. Sex Transm Dis (2001) 1.97

Awkward moments in patient-physician communication about HIV risk. Ann Intern Med (1998) 1.96

Frequency and thoroughness of STD/HIV risk assessment by physicians in a high-risk metropolitan area. Am J Public Health (1991) 1.71

Community-based urine screening for Chlamydia trachomatis with a ligase chain reaction assay. Ann Intern Med (1997) 1.60

Incidence and repeat infection rates of Chlamydia trachomatis among male and female patients in an STD clinic: implications for screening and rescreening. Sex Transm Dis (2002) 1.57

Delivery of STD/HIV preventive services to adolescents by primary care physicians. J Adolesc Health (1996) 1.39

GP's management of genital Chlamydia: a survey of reported practice. Fam Pract (1997) 1.35

Control of Chlamydia trachomatis infections in female army recruits: cost-effective screening and treatment in training cohorts to prevent pelvic inflammatory disease. Sex Transm Dis (1999) 1.28

Barriers to screening sexually active adolescent women for chlamydia: a survey of primary care physicians. J Adolesc Health (2001) 1.25

Screening high-risk adolescent males for Chlamydia trachomatis infection. Obtaining urine specimens in the field. Sex Transm Dis (1998) 1.21

Practice patterns for the elicitation of sexual history, education, and counseling among providers of STD services: results from the gonorrhea community action project (GCAP). Sex Transm Dis (1999) 1.18

Use of reproductive health services among young men, 1995. J Adolesc Health (2000) 1.10

Feasibility and yield of screening urine for Chlamydia trachomatis by polymerase chain reaction among high-risk male youth in field-based and other nonclinic settings. A new strategy for sexually transmitted disease control. Sex Transm Dis (1997) 1.09

Screening men for Chlamydia trachomatis infection: have we fully explored the possibilities? Commun Dis Public Health (2000) 1.08

Using unannounced standardized patients to assess the HIV preventive practices of family nurse practitioners and family physicians. Nurse Pract (1998) 0.96

Prevalence of Chlamydia trachomatis in young men in north west London. Sex Transm Infect (2000) 0.93

Performance of Massachusetts HMOs in providing Pap smear and sexually transmitted disease screening to adolescent females. J Adolesc Health (1998) 0.93

Health and cost-benefits of chlamydia screening in young women. Sex Transm Dis (1999) 0.91

Adolescent chlamydia testing practices and diagnosed infections in a large managed care organization. Sex Transm Dis (2001) 0.91

High prevalence of Chlamydia trachomatis infections in adolescent females not having pelvic examinations: utility of PCR-based urine screening in urban adolescent clinic setting. J Adolesc Health (1997) 0.86

Screening adolescents for sexually transmitted infections. JAMA (1998) 0.82

Chlamydia trachomatis screening in the adolescent population. Curr Opin Pediatr (1997) 0.78

Amplified DNA testing for sexually transmitted diseases: new opportunities and new questions. Arch Pediatr Adolesc Med (1999) 0.78

Evaluation of chlamydia and gonorrhea screening criteria: San Francisco sexually transmitted disease clinic: 1997 to 1998. Sex Transm Dis (2000) 0.78

Cost-effective screening for Chlamydia trachomatis: are DNA amplification assays the answer? Sex Transm Dis (1998) 0.78

Articles by these authors

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science (1997) 18.10

Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature (1997) 15.49

Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet (2001) 13.32

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat Med (1999) 12.68

Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study Group. Lancet (1999) 10.28

HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet (1997) 7.52

Direct detection of Chlamydia trachomatis in urine specimens from symptomatic and asymptomatic men by using a rapid polymerase chain reaction assay. J Clin Microbiol (1993) 6.21

AIDS in Africa: an epidemiologic paradigm. Science (1986) 5.88

Sex differences in HIV-1 viral load and progression to AIDS. Lancet (1998) 5.24

Ligase chain reaction to detect Chlamydia trachomatis infection of the cervix. J Clin Microbiol (1994) 5.15

Male circumcision and HIV acquisition and transmission: cohort studies in Rakai, Uganda. Rakai Project Team. AIDS (2000) 5.14

Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. N Engl J Med (1999) 5.05

Genital ulceration as a risk factor for human immunodeficiency virus infection. AIDS (1988) 4.85

Chlamydia trachomatis infections in female military recruits. N Engl J Med (1998) 4.68

Azithromycin in control of trachoma. Lancet (1999) 4.32

Characterization of Campylobacter-like organisms isolated from homosexual men. J Infect Dis (1984) 4.23

Spread of HIV infection in married monogamous women in India. JAMA (1997) 4.18

Incident Chlamydia trachomatis infections among inner-city adolescent females. JAMA (1998) 4.12

Multiply antibiotic-resistant Staphylococcus aureus: introduction, transmission, and evolution of nosocomial infection. Ann Intern Med (1982) 3.95

Diagnosis of Chlamydia trachomatis urethral infection in symptomatic and asymptomatic men by testing first-void urine in a ligase chain reaction assay. J Infect Dis (1994) 3.93

The avian influenza virus nucleoprotein gene and a specific constellation of avian and human virus polymerase genes each specify attenuation of avian-human influenza A/Pintail/79 reassortant viruses for monkeys. J Virol (1987) 3.76

Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group. N Engl J Med (1997) 3.71

Human immunodeficiency virus load in breast milk, mastitis, and mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis (1999) 3.69

Frequency and distribution in the United States of strains of Neisseria gonorrhoeae with plasmid-mediated, high-level resistance to tetracycline. J Infect Dis (1987) 3.62

A randomized, community trial of intensive sexually transmitted disease control for AIDS prevention, Rakai, Uganda. AIDS (1998) 3.54

Performance of the APTIMA Combo 2 assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in female urine and endocervical swab specimens. J Clin Microbiol (2003) 3.50

Estimation of current human immunodeficiency virus incidence rates from a cross-sectional survey using early diagnostic tests. Am J Epidemiol (1995) 3.44

Multicenter evaluation of the AMPLICOR and automated COBAS AMPLICOR CT/NG tests for detection of Chlamydia trachomatis. J Clin Microbiol (2000) 3.44

HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapy. JAMA (2001) 3.41

Risk factors for HIV infection in people attending clinics for sexually transmitted diseases in India. BMJ (1995) 3.38

National surveillance of antimicrobial resistance in Neisseria gonorrhoeae. The Gonococcal Isolate Surveillance Project. JAMA (1990) 3.25

Field testing and comparative evaluation of rapid, visually read screening assays for antibody to human immunodeficiency virus. Lancet (1989) 3.18

Diagnosis of Chlamydia trachomatis infections by direct immunofluorescence staining of genital secretions. A multicenter trial. Ann Intern Med (1984) 3.15

The polymicrobial origin of intestinal infections in homosexual men. N Engl J Med (1983) 3.12

Chlamydia trachomatis proctitis. N Engl J Med (1981) 3.02

Audio computer assisted self interview and face to face interview modes in assessing response bias among STD clinic patients. Sex Transm Infect (2005) 2.98

Diagnosis of Trichomonas vaginalis infection by PCR using vaginal swab samples. J Clin Microbiol (1998) 2.81

Multicenter evaluation of AMPLICOR and automated COBAS AMPLICOR CT/NG tests for Neisseria gonorrhoeae. J Clin Microbiol (2000) 2.80

Screening for Chlamydia trachomatis in asymptomatic women attending family planning clinics. A cost-effectiveness analysis of three strategies. Ann Intern Med (1998) 2.78

Assessment of neonatal conjunctivitis with a direct immunofluorescent monoclonal antibody stain for Chlamydia. JAMA (1986) 2.69

Initial plasma HIV-1 RNA levels and progression to AIDS in women and men. N Engl J Med (2001) 2.68

Infections with Campylobacter jejuni and Campylobacter-like organisms in homosexual men. Ann Intern Med (1984) 2.65

Evidence for high prevalence & rapid transmission of HIV among individuals attending STD clinics in Pune, India. Indian J Med Res (1996) 2.64

NIH conference. Gastrointestinal infections in AIDS. Ann Intern Med (1992) 2.62

Screening women for chlamydia trachomatis in family planning clinics: the cost-effectiveness of DNA amplification assays. Sex Transm Dis (1998) 2.60

The etiology of genital ulcer disease by multiplex polymerase chain reaction and relationship to HIV infection among patients attending sexually transmitted disease clinics in Pune, India. Sex Transm Dis (1999) 2.57

Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect Immun (1996) 2.52

Acquired immunodeficiency syndrome in a heterosexual population in Zaire. Lancet (1984) 2.43

Hepatitis B and hepatitis C in emergency department patients. N Engl J Med (1992) 2.39

Identification of Chlamydia pneumoniae by DNA amplification of the 16S rRNA gene. J Clin Microbiol (1992) 2.36

Pooling urine samples for ligase chain reaction screening for genital Chlamydia trachomatis infection in asymptomatic women. J Clin Microbiol (1998) 2.35

The B allele of the NS gene of avian influenza viruses, but not the A allele, attenuates a human influenza A virus for squirrel monkeys. Virology (1989) 2.32

Emergency department-based HIV screening and counseling: experience with rapid and standard serologic testing. Ann Emerg Med (1999) 2.31

Epidemiology of hepatitis E virus infection in Turkey. Lancet (1993) 2.29

Population-based study of fertility in women with HIV-1 infection in Uganda. Lancet (1998) 2.29

Herpes simplex virus infection as a risk factor for human immunodeficiency virus infection in heterosexuals. J Infect Dis (1992) 2.25

Biphasic decay of latently infected CD4+ T cells in acute human immunodeficiency virus type 1 infection. J Infect Dis (2000) 2.25

The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia. Proc Natl Acad Sci U S A (1997) 2.24

Detection of Neisseria gonorrhoeae and Chlamydia trachomatis in genitourinary specimens from men and women by a coamplification PCR assay. J Clin Microbiol (1997) 2.22

In vitro evaluation of CP-62,993, erythromycin, clindamycin, and tetracycline against Chlamydia trachomatis. Antimicrob Agents Chemother (1987) 2.21

Use of cell culture and a rapid diagnostic assay for Chlamydia trachomatis screening. JAMA (1994) 2.18

Unsuspected human immunodeficiency virus in critically ill emergency patients. JAMA (1987) 2.17

Evidence for HTLV-III infection in prostitutes in Tamil Nadu (India). Indian J Med Res (1987) 2.13

Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy. J Infect Dis (1996) 2.12

Coinfection with human T-cell lymphotropic virus type I and HIV in Brazil. Impact on markers of HIV disease progression. JAMA (1994) 2.11

High-level tetracycline resistance resulting from TetM in strains of Neisseria spp., Kingella denitrificans, and Eikenella corrodens. Antimicrob Agents Chemother (1988) 2.11

Stability of human immunodeficiency virus type 1 antibodies in whole blood dried on filter paper and stored under various tropical conditions in Kinshasa, Zaire. J Clin Microbiol (1992) 2.09

Role of the mononuclear phagocyte system in the immunopathogenesis of human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Rev Infect Dis (1989) 2.09

The human immunodeficiency virus epidemic in India. Current magnitude and future projections. Medicine (Baltimore) (1995) 2.09

Detection of Chlamydia trachomatis by the Gen-Probe AMPLIFIED Chlamydia Trachomatis Assay (AMP CT) in urine specimens from men and women and endocervical specimens from women. J Clin Microbiol (1998) 2.07

Evaluation of avian-human reassortant influenza A/Washington/897/80 x A/Pintail/119/79 virus in monkeys and adult volunteers. J Clin Microbiol (1986) 2.06

Reliability of partner reports of sexual history in a heterosexual population at a sexually transmitted diseases clinic. Sex Transm Dis (1997) 2.03

Risk factors and clinical presentation of acute primary HIV infection in India. JAMA (1997) 2.02

Detection and differentiation of Chlamydia trachomatis, Chlamydia psittaci, and Chlamydia pneumoniae by DNA amplification. J Infect Dis (1990) 1.98

Serologic and immunologic studies in patients with AIDS in North America and Africa. The potential role of infectious agents as cofactors in human immunodeficiency virus infection. JAMA (1987) 1.98

Herpes simplex virus proctitis in homosexual men. Clinical, sigmoidoscopic, and histopathological features. N Engl J Med (1983) 1.97

Circumcision and STD in the United States: cross sectional and cohort analyses. Sex Transm Infect (2000) 1.94

Enzyme-linked immunosorbent assay for the detection of Giardia lamblia in fecal specimens. J Infect Dis (1984) 1.93

Prevalence of enteric pathogens in homosexual men with and without acquired immunodeficiency syndrome. Gastroenterology (1988) 1.93

Prevalence of asymptomatic nasopharyngeal carriage of Chlamydia pneumoniae in subjectively healthy adults: assessment by polymerase chain reaction-enzyme immunoassay and culture. Clin Infect Dis (1995) 1.86

Hematologic abnormalities in the acquired immune deficiency syndrome. Am J Med (1984) 1.85

Molecular amplification assays to detect chlamydial infections in urine specimens from high school female students and to monitor the persistence of chlamydial DNA after therapy. J Infect Dis (1998) 1.83

Condom use and HIV infection among prostitutes in Zaire. N Engl J Med (1987) 1.82

Screening for Chlamydia trachomatis infection in an inner-city population: a comparison of diagnostic methods. J Infect Dis (1985) 1.81

Effect of age and preexisting antibody on serum antibody response of infants and children to the F and G glycoproteins during respiratory syncytial virus infection. J Clin Microbiol (1986) 1.79

Hepatitis C, hepatitis B, and human immunodeficiency virus infections among non-intravenous drug-using patients attending clinics for sexually transmitted diseases. J Infect Dis (1994) 1.78

Substantial increase in human immunodeficiency virus (HIV-1) infection in critically ill emergency patients: 1986 and 1987 compared. Ann Emerg Med (1989) 1.78

Demonstration of chlamydial RNA and DNA during a culture-negative state. Infect Immun (1992) 1.77

Viral hepatitis in health care personnel at The Johns Hopkins Hospital. The seroprevalence of and risk factors for hepatitis B virus and hepatitis C virus infection. Arch Intern Med (1993) 1.76

Syphilis serology in human immunodeficiency virus infection: evidence for false-negative fluorescent treponemal testing. J Infect Dis (1997) 1.74

Enhancing the specificity of the COBAS AMPLICOR CT/NG test for Neisseria gonorrhoeae by retesting specimens with equivocal results. J Clin Microbiol (2001) 1.73

Geographic epidemiology of gonorrhea in Baltimore, Maryland, using a geographic information system. Am J Epidemiol (1998) 1.73

Prevalence and incidence of hepatitis C virus infection among male prison inmates in Maryland. Eur J Epidemiol (1993) 1.73

Randomized trial of presumptive sexually transmitted disease therapy during pregnancy in Rakai, Uganda. Am J Obstet Gynecol (2001) 1.72

Intestinal spirochetosis in homosexual men. Am J Med (1987) 1.72

Unsuspected gonorrhea and chlamydia in patients of an urban adult emergency department: a critical population for STD control intervention. Sex Transm Dis (2001) 1.70

Evaluation of use of a single intravaginal swab to detect multiple sexually transmitted infections in active-duty military women. Clin Infect Dis (2001) 1.66

Bacterial vaginosis in lesbians: a sexually transmitted disease. Clin Infect Dis (1995) 1.65